In cellular models of cardiomyocyte hypertrophy, a form of heart enlargement that causes heart failure, overexpression of PRMT5 results in the reduction of isoprenaline-induced hypertrophy through repressive methylation of HOXA9, a gene that plays a critical role in the development of several cardiovascular diseases [73]. The gene discussed is PRMT5; the disease is cardiovascular disorder.